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Summary 
In human B lymphoblastoid cell lines, the majority of major histocompatibility complex (MHC) 
class II heterodimers are located on the cell surface and in endocytic compartments,  while invar- 
iant chain (Ii)-associated class II molecules represent biosynthetic intermediates which are present 
mostly in the endoplasmic reticulum and Golgi complex. To investigate the origin of the MHC 
class II-positive compartments and their relation to early endosomes, the intracellular distribu- 
tion of MHC class II molecules and Ii in relation  to endocytic tracers was studied in human 
lymphoblastoid B cells by immunoelectronmicroscopy on ultrathin cryosections. Cross-linking 
of surface immunoglobulins,  followed by a brief period of internalization  of the immune com- 
plexes, did not alter the intracellular distribution of MHC class II molecules. While early endo- 
somes were abundantly labeled for the cross-linked immunoglobulins,  < 1% of total MHC class 
II molecules were detectable in early endosomes. MHC class II- and Ii-positive structures as- 
sociated with the trans-Golgi  network can be reached by endocytosed bovine serum albumin 
(BSA)-gold conjugates after 30 min of internalization.  Prolonged exposure to BSA-gold allowed 
visualization of later endocytic compartments,  in which a progressive loss of Ii was observed: 
first the lumenal portion, and then the cytoplasmic portion of Ii escaped detection, culminating 
in the formation of MHC class II-positive compartments  (MIIC) devoid of Ii. The loss of Ii 
also correlated with a transition from a multivesicular to a multilaminar,  electron-dense MIIC. 
The intracellular compartments in which class II molecules reside (MIIC) are therefore a hetero- 
geneous  set of structures,  part  of the later  aspects of the endocytic pathway. 
I 
n human B lymphoblastoid cells, newly synthesized MHC 
class II molecules enter the endocytic pathway during bio- 
synthesis, before their arrival at the cell surface (1-3). In the 
endocytic pathway, antigenic peptides are generated by pro- 
teolysis and are made available for binding to MHC class II 
molecules. However, the exact location of class II molecules 
in the endosomal/lysosomal route in this cell type is under 
debate (4-6). Here we report that the distribution of MHC 
class II molecules in the human B lymphoblastoid cell line 
IM9 (4)  is indistinguishable  from that  previously reported 
(5) for theJY cell line, and that we cannot detect MHC class 
II molecules in early endosomes at levels >1% of total class 
II content.  Colocalization of MHC class II molecules with 
endocytosed Ig in early endosomes was reported by Guagliardi 
P. J. Peters and G. Raposo contributed equally to this report. 
et al. (4) for the human B cell line IM9, using immunogold 
labeling of osmium-fixed,  plastic-embedded cells.  Peters et 
al.  (5), using ultrathin  cryosections, reported  the presence 
of class II molecules in lysosomal structures  (referred to as 
MHC class II compartments  [MIIC] 1) in the human B cell 
line JY (5). The discrepancy between these studies might be 
explained by cell type-specific differences (6,  7),  or by ex- 
posure of the B cells to anti-Ig reagents to induce internali- 
zation of surface Ig in the former (4) but not in the latter 
(5)  study (6,  7).  The use of such reagents  entails the risk 
1 Abbreviations used in this paper: CIIV, MHC class II-enriched fraction; 
ICC, invariant chain carboxy terminus; li, invariant chain; ICN, invar- 
iant chain amino terminus; Lamp-l, lysosomal-associated  membrane pro- 
tein; MIIC, MHC class II compartment; MPR, mannose-6-phosphate 
receptor; Tf/HRP, transferrin-horseradish peroxidase; TGN, trans-Golgi 
network. 
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bution of MHC class II molecules in ultrathin frozen sec- 
tions from the IM9 cell line and found no evidence for the 
presence of class II molecules in early endosomes. The point 
of entry of class II molecules in the endocytic route and the 
relative position of MIIC in the antigen processing pathway 
have not been adequately resolved. This issue is of relevance 
in light of the proposed function of the class II-associated 
invariant chain (Ii).  The Ii chain targets class II molecules 
to endocytic structures and dissociates  from class II mole- 
cules soon after the ot3Ii complex has left the Golgi. Release 
of Ii from the ol3 heterodimer is a prerequisite for peptide 
binding. To explore in more detail the site of encounter of 
endocytosed materials with class II molecules in relationship 
to removal of Ii, we followed in parallel the fate of both en- 
docytic tracers  and Ii. We provide evidence that endocytic 
tracers  contact class II molecules in a compartment that is 
still positive for Ii, while the MIIC in its mature form, the 
most abundant source of intracellular class II molecules, is 
devoid of Ii. We conclude that antigen and class II molecules 
may first meet in trans-Golgi network (TGN)-associated, Ii- 
positive structures, from which MIIC are developed,  a pro- 
cess accompanied by destruction of the Ii chain. 
Materials and Methods 
Cells.  The human B cell line IM9 was obtained from the Amer- 
ican Type Culture Collection (Rockville, MD) and maintained in 
RPMI 1640 medium supplemented  with 10% (vol/vol)  FCS, 2 mM 
glutamine, and penicillin/streptomycin at 100 IU and 100/~g/ml, 
respectively. The human B cell line JY has been described (2, 5). 
Immunostaining.  Before  incubation with a transferrin-horse- 
radish peroxidase (Tf/HRP) conjugate (8), to deplete the cells of 
transferrin, the cells were maintained in serum-free RPMI 1640 
medium for two consecutive  incubations of 20 min each. The cells 
were then incubated with 25/zg/ml of Tf/HRP (8) for 5 min or 
10 rain at 37~  followed by fixation in 0.5% glutaraldehyde in 
0.1 M phosphate buffer at 37~  and processed for electron mi- 
croscopy as described (5). MHC class II molecules were labeled 
with rabbit anti-class II oe serum (2, 5) at a dilution of 1:600. HRP 
was immunolabeled with anti-HRP (Sigma Immunochemicals,  St. 
Louis, MO) at a dilution of 1:300. Antisera directed against the 
invariant chain carboxy terminus (ICC) and invariant chain amino 
terminus (ICN) were used at a dilution of (1:200). ICC and ICN 
have been generated by Phil Morton (Monsanto Chemical Co., St. 
Louis, MO).  For ICC and ICN, a 0.2%  glutaraldehyde fixative 
for 30 min was used. Cathepsin D antibodies have been described 
(5). Immunoglobulins were visualized using the protein A-gold 
technique (9). Surface immunoglobulins were labeled by a sand- 
wich procedure essentially as described by Guagliardi et al. (4). 
However, to eliminate the risk of false positive labeling, endocy- 
tosed Ig was visualized after fixation, rather than by using prela- 
beled anti-Ig reagents during endocytosis. Specifically, IM9 cells 
were washed twice with PBS and were incubated with rabbit 
anti-human ~ light chain immunoglobulin (Central Laboratories 
of the Red  Cross Blood Transfusion Service Amsterdam, The 
Netherlands) diluted 1:40, for 30 min at 0~  Unbound Ig were 
removed by washing with PBS at 0~  Cells were then transferred 
to 37~  for 2 or 10 rain and fixed with glutaraldehyde as described 
above. Ultrathin  sections were immunolabeled with swine anti- 
rabbit immunoglobulins (dilution 1:3,000; Nordic Immunological 
Laboratories, Capistrano Beach, CA) and protein A-gold.  BSA- 
gold was applied to the cells for 10 rain and chased for 20 rain 
as described. Sections  were processed for and examined  by electron 
microscopy as described (5). 
]~esults 
To examine whether class II molecules localize  to com- 
partments in which cross-linked surface Ig is found after a 
brief period of internalization, we examined the B lympho- 
blastoid cell line IM9 and looked for the presence  of class 
II molecules in early endosomes. After immunolabeling of 
ultrathin cryosections prepared from IM9, we observed a sub- 
cellular distribution (including endoplasmic reticulum [ER] 
and Golgi region) for MHC class II molecules that was very 
similar to that observed in JY cells (2, 5). We labeled early 
endosomes in IM9 cells (4) by internalization of a Tf/HRP 
(10) for 5 rain (Fig. 1, A-C).  The cell surface was labeled 
for MHC class II molecules (Figs.  1 A and 2, A and B) and 
also Tf/HRP (Fig.  1 B). Tf/HRP, but no MHC class II, 
was present in coated pits (Fig. 1 B) and in early endosomes 
(Fig.  1 A-C) (8).  The level of class II staining (measured 
as gold particles per square micrometer) observed in early 
endosomes of IM9 cells and JY cells (5) did not exceed 1% 
of the total. No Tf/HRP could be detected in MIIC. We 
next labeled early endosomes by an alternative method (4). 
Surface immunoglobulins were cross-linked with heterolo- 
gous antibodies in a three-step sandwich procedure (at 0~ 
and allowed to internalize for 2 rain at 37~  (4) (Fig. 2). 
Early endosomal structures contained heterologous Ig,  as 
reported (4), but no class II molecules were observed in the 
immunoglobulin-positive endosomes. 
In contrast to the earlier report (4), early endosomes, as 
defined by internalization of Tf/HRP (8), were negative for 
cathepsin D, whereas other membrane-delimited structures 
did stain for it (Fig. 3). Early endosomes, therefore, are com- 
partments distinct from MIIC. 
Compartments labeled for class II, but not for class I mol- 
ecules and mannose-6-phosphate receptors (MPR), were also 
detected in IM9 cells (data not shown). These compartments 
contained the lysosomal markers lysosomal-associated mem- 
brane protein (Lamp-l) and cathepsin D (14) (data not shown) 
and have been defined as MIIC (5), which are late endocytic 
structures closely related to lysosomes. When the appear- 
ance of BSA-gold in class II-positive structures was exam- 
ined, the endocytic tracer reached MIIC, which are Lamp-1 
positive, after 30 min. We examined the distribution of  MHC 
class II molecules and of Lamp-1 in compartments that were 
labeled by endocytosis of BSA-gold. As shown in Table 1, 
there is a progressive increase in endocytic delivery of BSA- 
gold to MIIC that express Lamp-1. Of the class II-positive 
structures that do not stain for Lamp-l, we find only modest 
numbers that are labeled by the endocytic tracer. Lysosomes 
not labeled  for MHC class II molecules were present (5). 
Structures colabeling for Lamp-l, cathepsin D, and MHC 
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II compartments are distinct. Early endo- 
somes were  identified  in IM9 cells  by allowing 
internalization of Tf/HRP for 5 min. After 
fixation, ultrathin sections  were prepared  and 
labeled with anti--class II and anti-HRP an- 
tibodies. No colocalization  of Tf/HRP and 
MHC class II molecules  is observed  in these 
early endocytic vesicles. Bar, 100 nm.  (A) 
Class II molecules  were labeled  with 15 nm 
gold and Tf/HRP with 10 nm gold. (B and 
C) Class II molecules  were labeled with 10 
nm gold, and Tf/HRP with  15 nm gold. 
MHC class II molecules are located at the 
plasma membranes (p; A) and in MIIC (II; 
A  and  C).  Tf/HRP  is  located in  small 
vesicles, in vacuolar and tubular (A, arrow- 
head) structures. The Golgi apparatus (g) is 
not labeled for Tf/HRP (C). Note the ab- 
sence of class II molecules  in Tf/HRP-con- 
raining endosomes (e) Mitochondria (m) are 
devoid of label. 
class II molecules have likewise been observed in mouse mac- 
rophages  (13). 
Having established that the site of encounter between class 
II molecules and endocytosed material is not the early endo- 
some, we sought to determine more precisely at which stage 
of the maturation pathway of class II molecules the intersec- 
tion with the endocytic pathway occurs.  For that purpose, 
we exploited antibodies directed against the lumenal and cy- 
toplasmic portions of Ii,  since it is known  that during  the 
course of class II molecule maturation,  li is lost by proteol- 
ysis.  We examined the distribution  of Ii in relation  to en- 
docytosed (10-min pulse, 20-rain chase) BSA-gold conjugates. 
The  invariant  chain  was  followed using  rabbit  antibodies 
directed  against  the  NH2-terminal,  cytoplasmic  portion 
(ICN) and against the COOH-terminal, luminal part (ICC). 
Immunoreactivity with both antibodies was observed in the 
Elk,  indicative of the presence of intact  Ii at  that  location 
(Fig.  4 A).  Whereas  the lumenal Ii epitope was detectable 
in the Golgi and in some MIIC (Fig. 4 B), it was not usually 
observed in MIIC devoid of BSA-gold under these conditions 
(Fig. 4 B). The MIIC strongly labeled for class II molecules 
in the same section are negative for endocytosed BSA-gold 
(Fig. 4 B).  We conclude that MIIC,  devoid of the lumenal 
portion of Ii, are located late in the endocytic pathway. How- 
ever, on occasion we did observe ICC-positive structures that 
were multivesicular  and  reachable by BSA-gold after a  10- 
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colocalize  with internalized immunoglobulin 
in early endosomes. Surface  immunoglobulin 
was labeled by a sandwich procedure essen- 
tially as described by Guagliardi et al. (4). 
However, endocytosed  Ig was visualized  after 
fixation  rather  than  by  using  prelabeled 
anti-Ig reagents during endocytosis (4). (A) 
Class II molecules (gold 15 nm) are located 
on the cell surface and heterologous Ig (gold 
10 rim) is located at the plasma membrane 
(v), in a coated pit and endocytic vesicles 
(arrows). These vesicles are of a size (,o100 
nm) that is characteristic for early endocytic 
structures. (11, 12). Bar, 100 nm. (B) MHC 
class II molecules (gold 15 nm) are located 
at the plasma membrane (p), and heterolog- 
ous Ig is located at the plasma membrane and 
in endocytic vacuoles (e) with a characteristic 
size of ,0500 nm (11, 12). Note that no class 
II molecules are detected in these endocytic 
structures. Bar, 100 rim. (C) Class II mole- 
cules (gold 15 nm) are located in character- 
istic, electron dense MIIC (13). Heterologous 
Ig (small  gold, 10 nm) is located in endosomal 
structures (e). Note the complete segregation 
of class II molecules and endocytosed heter- 
ologous Ig. Bar, 100 nm. 
Figure 3.  Endocytic structures containing 
internalized Ig do not label for cathepsin D. 
Immunoglobulins  on IM9 cells  were allowed 
to internalize for 2 min, as described in Fig. 
2. Ultrathin sections were double labeled for 
immunoglobulin  (15 nm gold) and cathepsin 
D (10 nm gold) The early endosomes (e) la- 
beled for endocytosed immunoglobulin  were 
not labeled for cathepsin D. Lysosomes (I) 
labeled for catbepsin D were not labeled for 
internalized heterologous immunoglobulin. 
The plasma membrane ~) is not labeled for 
cathepsin D. Bar, 100 rim. 
Table  1.  Appearance  of BSA-Gold  in  MHC 
Class  II-positive  lntracellular  Structures 
Time*  MIIC (Lamp-1 +)  Other  (Lamp-I-) 
min 
10  --  -- 
30  375  2 
0  58  8 
* Time of exposure  to BSA-gold (5 nm) 
# Number of BSA-gold positive  structures. 
MIIC were identified based on their class II content and morphological 
appearance. Most MIIC are Lamp-1 positive (5). We detect small num- 
bers of class II positive structures  that do not stain for Lamp-l, referred 
to as "other." 
rain pulse and a 20-rain chase (Fig. 5). These compartments, 
positioned distal from the Golgi because of their endocytic 
nature,  showed weak staining for MHC  class  II products, 
possibly because of steric hindrance caused by the anti-ICC 
protein A-gold complex used in the first incubation step. We 
conclude that endocytosed material can first contact class II 
molecules in a compartment containing intact Ii. Compart- 
ments can be classified  as MIIC on morphological criteria: 
they are either multivesicular (Fig. 4 B), multilaminar (Fig. 
1), or both (Fig. 5). MIIC occur in three manifestations based 
on Ii content: those that contain intact Ii because they are 
positive for both lumenal (ICC) and cytoplasmic (ICN) epi- 
topes of Ii; those that contain the proteolysed NH2-terminal 
fragment of Ii, positive for the cytoplasmic (ICN) Ii epitope 
only; and MIIC  that  are altogether negative for Ii.  Fig.  6 
shows MIIC that are positive for both Ii epitopes (upper left 
quadrant), MIIC that are positive for the cytoplasmic (ICN) 
Ii epitope only (lower left quadrant), and an Ii-negative MIIC 
in the central portion of the micrograph. At a lower mag- 
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in the ER and in the Golgi.  (A)JY  cells  were 
sectioned  and stained  with antibodies  against 
the COOH- and NH2-terminal portion of 
invariant  chain,  ICC, and ICN, respectively, 
and decorated  with 15 (ICC) and 10 (ICN) 
nm gold. n, nucleus; m, mitochondrion;  p, 
plasma membrane. Bar, 100 rim. (B) Same 
as A, but on cells exposed to BSA gold for 
a 10-min  pulse  and a 20-min  chase. Note the 
presence of the BSA-gold  (5 nm) conjugate 
at the cell surface  and in an early  endosome. 
In this  field,  all immunoreactivity  with ICC 
(Ii lumenal  portion) is confined  to the ER. 
MIIC, identified  by the 10-nm gold parti- 
cles, are negative  for Ii and endocytosed  BSA- 
gold. 
nification that shows MIIC visible in greater numbers, it is 
clear  that MIIC that are negative for the lumenal epitope 
of Ii far outnumber those that contain it (Fig. 7, arrowheads, 
Ii, lumenal fragment; asterisks, Ii-negative MIIC). Quantita- 
tive analysis (50 cells analyzed) reveals that 46% of all MIIC 
lack any detectable Ii. The remaining 54% have retained the 
cytoplasmic portion of Ii, and of these, 31% are positive for 
the lumenal domain.  Importantly, all of the ICC-positive 
MIIC also stain for ICN.  Similar  values were obtained for 
two other EBV-transformed  B lymphoblastoid cell lines (data 
not shown).  We therefore suggest that the loss of the lu- 
menal fragment precedes that of the cytoplasmic portion, in 
agreement with the results from biochemical experiments. 
Inhibition of Ii breakdown, as brought about by blocking 
the activity of the vacuolar H + ATPase, results in the gener- 
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ation of •11-kD  fragments that contain the cytoplasmic por- 
tion of Ii (16). These fragments are of a size that could still 
contain the CLIP region that is inhibitory for peptide binding 
(19). Results from subcellular  fractionation experiments on 
murine B cells pulsed in the presence of the protease inhib- 
itor leupeptin reveal the existence, during the pulse, of a similar 
11-kD fragment in compartments in which peptide loading 
of class II molecules is inhibited in the presence of leupeptin; 
during a chase,  in the absence of leupeptin, the disappear- 
ance of the 11-kD fragment is accompanied by a conversion 
of class II molecules to the peptide-occupied form (20). 
Discussion 
The data shown here are consistent with proposals for the 
site of generation of peptides for presentation by class II mol- Figure  5.  Encounter of endocytosed BSA- 
gold in MIIC that contain the lumenal por- 
tion ofli. JY cells were exposed to BSA-gold 
(5 nm) and prepared for immunoelectron mi- 
croscopy, as described in Fig. 4. Most of the 
MIIC visible in this field, while positive for 
class II (10 nm gold), are negative for endocy- 
tosed BSA-gold and negative for the lumenal 
epitope of Ii (15 nm gold). The single MIIC 
that is positive for BSA-gold (arrow) is posi- 
tive also for the lumenal epitope (ICC) of Ii. 
Staining  intensity  for class II is reduced in 
this compartment  for reasons discussed in the 
text.  m, mitochondrion.  Bar, 100 nm. 
ecules in mouse cells (21, 22) and human cells (17), in which 
emphasis is placed on late aspects of the endocytic route (15, 
17, 18).  It has been suggested that a sizable fraction of MHC 
class II molecules may reach endocytic compartments by in- 
sertion at and rapid internalization from the cell surface (24, 
25). In class II-positive mouse B cell lines, a significant frac- 
tion of class II molecules have been reported to recycle,  and 
they have been recovered from early endosomal fractions (26). 
In mouse macrophages, class II molecules do not recycle and 
are  found  predominantly  in late  endocytic  structures.  For 
Figure  6.  Two distinct  types of invariant 
chain-positive MIIC. JY cells were prepared 
for immunoelectron  microscopy as described 
in the legend to Fig. 4.  Staining  was per- 
formed  with  antibodies  against  the cyto- 
plasmic  NH2-terminal  portion of Ii (ICN; 
10 nm gold) and  with antibodies  directed 
against the lumenal COOH-terminal portion 
of Ii (ICC; 15 nm gold).  The MIIC that is 
positive for ICC is also positive for ICN (upper 
left quadrant).  The two MIIC in the lower 
left quadrant are positive for ICN, but nega- 
tive for the lumenal  epitope.  The MIIC in 
the central portion of this field is positive for 
neither, p, plasma membrane.  Bar, 100 nm. 
330  Major Histocompatibility Class II Compartments Figure 7.  Most  MIIC are negative  for the lumenal 
portion of invariant chain. Most of the MIIC present 
in this field  are positive for class II (10 nm gold) and 
negative for the lumenal  epitope of li (asterisks).  A far 
smaller  number  of  ICC-positive  structures  (15 nm gold) 
is observed, m, mitochondrion;  n, nucleus;  g, Golgi  ap- 
paratus. Bar, 500 nm. 
human B lymphoblastoid cell lines, spontaneous internaliza- 
tion of surface-disposed  class II molecules is a minor process 
(2, 27), but internalization and recycling have been observed 
(28). Intracellular trafficking of MHC class II molecules may 
be modified considerably in cells in which the intracellular 
acidic compartments have been neutralized (16). Our recent 
results obtained in human B cells exposed to the vacuolar 
H + pump inhibitor concanamycin B, an agent that blocks 
early to late endosomal trafficking, show the direct route of 
delivery of  class II molecules from the TGN to the endocytic 
pathway to be the most prevalent (16). Under normal condi- 
tions, a fraction of dass II molecules is delivered  to the cell 
surface and indeed reaches  the endocytic pathway by inter- 
nalization, but this pathway appears to be rather minor (16), 
and it can account for our inability to detect any class II mol- 
ecules in early endosomes. The results shown here allow the 
conclusion that at steady state, no more than 1% of all class 
II molecules are found in early endosomes. However, immu- 
nocytochemistry is unlikely to reveal compartments that are 
used in transit and are occupied by the molecules of interest 
for a brief period only: their steady state levels would be too 
low to  allow detection by immunoelectron microscopy, a 
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method quantitative only as far as equilibrium levels are con- 
cerned. 
An earlier report (1) was the first to describe the suscepti- 
bility of biosynthetically labeled class II molecules to enzy- 
matic attack by an endocytosed transferrin-neuraminidase  con- 
jugate, suggestive of involvement of early endosomes as the 
site of encounter. However, not all of this conjugate was found 
to recycle, nor could all of the neuraminidase in the conjugate 
be immunoprecipitated with antitransferrin antibodies (1), 
leaving open the possibility of the conjugate or free enzyme 
penetrating deep into the endocytic pathway, and reaching 
late endosomes or even lysosomes in an active form. While 
establishing the important concept of intersecting intracel- 
lular routes of class II molecules and endocytosed materials, 
these experiments did not address the issue of whether early, 
as opposed to late endosomes, are the intracellular site of en- 
counter of antigen and class II molecules. 
The present results also establish  that in human B lym- 
phoblastoid cells, the most likely site of encounter of MHC 
class II molecules and antigen, is not the early endosome, 
but a late endocytic structure. We show that structures that 
are Ii-positive and emanate from the TGN (29) can be ad- dressed by endocytosed BSA-gold, but only after prolonged 
incubation  (30 min).  The  majority of characteristic  MIIC 
is devoid of Ii, as detected by antibodies directed against the 
luminal epitope (Fig. 7). We observed MIIC that stained for 
the cytoplasmic portion of Ii, and less frequently did we ob- 
serve MIIC, as identified by class II content and morphology- 
positive for the lumenal portion of Ii; these MIIC invariably 
stained for the cytoplasmic portion of Ii as well.  We there- 
fore suggest that the MIIC are derived from TGN-associated, 
Ii-positive structures,  a process accompanied by progressive 
destruction  of Ii.  The  lumenal  epitope  is  destroyed first, 
followed by the removal of the  NH2-terminal  cytoplasmic 
fragment. 
Removal of Ii from the class II ot3Ii complex is required 
for peptide binding to occur.  Class II molecules, located in 
the TGN-associated,  Ii-positive compartments,  are unlikely 
to be fully occupied by peptide and the peptide loading pro- 
cess may not be complete until  the class  II molecules have 
reached MIIC. The shortest fragment of Ii capable of stable 
interaction with class II molecules, as studied by in vitro trans- 
lation (19),  is segment 1-104, and prevents peptide binding. 
If its removal is a necessary condition for peptide loading to 
occur, our data suggest that in human B lymphoblastoid cells, 
this  process  indeed  takes  place  mostly in  the  MIIC.  This 
scheme suggests that  endocytosed materials  may be found 
in Ii-positive compartments,  and that  the pathway traveled 
by endocytosed antigens may be parallel to that of ot3Ii com- 
plexes for the later part of the endocytic pathway. Breakdown 
of Ii and breakdown of antigen into suitably sized peptides 
would thus take place synchronously, and a class II-binding 
site, liberated by removal of Ii, could immediately be occupied 
by newly generated peptide. Our earlier electron microscopy 
observations (5) were made using predominantly anti-class 
II antibodies.  The availability of antibodies directed against 
the luminal and cytosolic domain of Ii allowed us to explore 
the generation  of MIIC and the steps that  precede it.  Our 
earlier model proposed a direct transfer of class II molecules 
to MIIC,  a  site at  which  the encounter  with  antigen  was 
proposed to take place (Fig. 8 B). The earlier data together 
with the present results indicate that MIIC dearly represent 
a heterogeneous set of structures, both by morphology and 
by access to endocytic tracers.  MIIC addressed relatively early 
by endocytic tracers are mostly multivesicular, whereas those 
that  are accessible later are often multilaminar.  The present 
data are consistent with a model in which the intersection 
of the pathway travelled by endocytosed material,  as well as 
that  of newly synthesized class  II molecules takes place at 
a site in close proximity of, if not contiguous with, the TGN 
(Fig.  8 A).  The recent reports  (15,  17,  18) of the isolation 
of compartments  positioned in the endocytic pathway and 
positive for class II may now be interpreted in the light  of 
the scheme proposed in Fig. 8 A. The occurrence of a heter- 
ogeneous set of endocytic structures, encompassing elements 
of the TGN (Geuze, H. J., personal communication) as well 
as MIIC, would be the expected result. Amigorena et al. (15) 
identified a class II--enriched fraction called CIIV that is Lamp- 
negative,  and by this criteria,  is a likely candidate for the TGN- 
Figure  8.  Trafficking  of MHC class II molecules and the endocytic 
pathway. (A) Scheme based on the data presented in (15, 16) and in the 
present study; the endocytic  pathway is indicated  by a large open arrow, 
and includes  early  endosomes,  late  endosomes,  and MIIC in linear progres- 
sion. The pathway traveled by MHC class II molecules  is indicated by 
the shaded portion of the arrow. We propose that the MIIC identified 
by Amigorena and colleagues (15) may be positioned in the area of the 
TGN, immediately upstream of MIIC. As CIIV and MIIC are similar 
yet distinct, they may represent overlapping populations of a heteroge- 
neous MHC class II-positive, endocytic  compartment. (B) Scheme  based 
on earlier studies (5) in which a direct transfer of class II molecules  from 
the TGN to MIIC was proposed. Note that in this scheme, there is little 
room for maturation of MIIC through progressive  loss of Ii or for hetero- 
geneity  in class II-positive  structures that would account for the observed 
differences between CIIV (15) and MIIC (5, 17, 18). 
associated endocytic structures identified in the present study. 
The morphological data and the subcellular fractionation ex- 
periments would be consistent with the identity of CIIV with 
the TGN-associated endocytic structures, which may be con- 
sidered  early  MIIC.  Note  that  the  majority  of MIIC  are 
Lamp-1 positive (15), unlike CIIV (Table 1). Structures resem- 
bling MIIC were found infrequently (1-2 per cell cross-section) 
in the murine A20 cells used for the subcellular fractionation 
experiments (15). In the human B lymphoblastoid cells ana- 
lyzed in the present  study,  the average number of MIIC is 
in excess of 20 per cell (see Fig. 7 for a typical example). CIIV 
are connected to the endocytic pathway, although not all frac- 
tions addressed by endocytic tracers were class II positive (15). 
The presence of transferrin  receptors in  the  CIIV  fraction 
is a further  argument  in favor of the notion that  CIIV are 
332  Major  Histocompatibility  Class II Compartments distinct from MIIC, and that CIIV are positioned closer to 
the TGN, both spatially and temporally. This argument makes 
the assumption that the CIIV fraction is not contaminated 
with a Tfr-positive compartment that displays electrophoretic 
properties identical to CIIV. Note that the scheme proposed 
in Fig. 8 B is not easily reconciled with the existence of CIIV, 
whereas the alternate scheme (Fig. 8 A) requires it. The rela- 
tive abundance of CIIV and MIIC may well relate to the 
differentiation state of the APC under consideration. Our 
present data do not address the mechanism of class II mole- 
cule transfer between CIIV and MIIC, but we suspect  this 
may be a rapid process, in agreement with the observations 
of Amigorena et al. (15), who conclude that loss of Ii must 
take place around the time class II molecules have reached 
CIIV. Our observations indicate that a sizable number of MIIC 
stain for the cytoplasmic portion of Ii, and it is this fraction 
that could perhaps  correspond  to  the  CIIV  identified by 
Amigorena et al.  (15). 
The route travelled by peptide-occupied class II molecules 
to the cell surface has not yet been visualized. Lysosomal con- 
stituents can be released to the extracellular milieu by regu- 
lated secretory events (29,  30).  Whether a similar situation 
applies to delivery of peptide-loaded class II molecules from 
MIIC to the cell surface of the APC is a possibility that seems 
likely in light of recent results obtained for human dendritic 
ceils (31). Exposure of dendritic cells to GM-CSF and IL-4 
causes redistribution of intracellularly disposed class II mole- 
cules to the cell surface. This observation raises the exciting 
possibility that cytokines, produced early during an immune 
response,  contribute to more effcient antigen presentation 
by controlling trafficking and display of peptide-loaded class 
II molecules. The slow transfer of peptide-occupied class II 
molecules to the cell surface from the MIIC in B lympho- 
blastoid cells may represent a rate-controlling default mecha- 
nism that would otherwise be a target for cytokine-imposed 
control. 
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